Amid Covid concerns in India, centre says no need for second dose of Covid vaccine booster shot

On Tuesday, India saw a single-day rise of 134 in coronavirus infections, with the active cases declining to 2,582, according to the Union Health Ministry data updated on Tuesday. The total tally of Covid cases was recorded at 4.46 crore (4,46,78,956).

News18
January 03, 2023 / 01:39 PM IST

(Representative image: Reuters)

With a rising concern for Covid-19 and its sub-variant Omicron XBB in India, the government on Tuesday said there is no need for a second dose of the booster or precautionary vaccine shot. “First we have to complete the booster drive in the country," said the government sources.

On Tuesday, India saw a single-day rise of 134 in coronavirus infections, with the active cases declining to 2,582, according to the Union Health Ministry data updated on Tuesday. The total tally of Covid cases was recorded at 4.46 crore (4,46,78,956).

The overall death toll to date stands at 5,30,707, the data updated at 8 am stated.

Meanwhile, Union Health Minister Mansukh Mandaviya Monday reviewed the screening and Covid testing facility at the Delhi Indira Gandhi International Airport amid a rise in coronavirus cases in some countries, including China.

The government has made random Covid tests mandatory for two per cent of passengers arriving on each international flight irrespective of their port of departure.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Besides, passengers arriving in India from China, Hong Kong, Japan, South Korea, Singapore and Thailand are being mandatorily required to provide Covid negative reports from January 1.

India’s active caseload currently stands at 2,582, with 134 new cases recorded in the last 24 hours, as per Union Health Ministry data.

As per ministry data, a total of 220.11 cr vaccine doses (95.13 cr Second Dose and 22.41 cr Precaution Dose) have been administered so far under Nationwide Vaccination Drive.
News18
Tags: #coronavirus #Covid-19 #Current Affairs #India #vaccine
first published: Jan 3, 2023 01:39 pm